Similar articles

• Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.

  Coy DH, Meyers C, Arimura A, Schally AV, Redding TW. Coy DH, et al. Metabolism. 1978 Sep;27(9 Suppl 1):1407-10. doi: 10.1016/0026-0495(78)90083-5. Metabolism. 1978. PMID: 683009 No abstract available.
• Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.

  Efendić S, Lins PE, Luft R, Sievertsson H, Westin-Sjödal G. Efendić S, et al. Acta Endocrinol (Copenh). 1977 Jul;85(3):579-86. Acta Endocrinol (Copenh). 1977. PMID: 194446
• Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.

  Grant N, Clark D, Garsky V, Jaunakais I, McGregor W, Sarantakis D. Grant N, et al. Life Sci. 1976 Sep 1;19(5):629-31. doi: 10.1016/0024-3205(76)90158-2. Life Sci. 1976. PMID: 957897 No abstract available.
• Somatostatin, basic and clinical studies. A review.

  Schally AV, Meyers CA. Schally AV, et al. Mater Med Pol. 1980 Jan-Jun;12(1-2):28-32. Mater Med Pol. 1980. PMID: 6120265 Review. No abstract available.
• Somatostatin.

  Efendić S, Hökfelt T, Luft R. Efendić S, et al. Adv Metab Disord. 1978;9:367-424. doi: 10.1016/b978-0-12-027309-6.50023-9. Adv Metab Disord. 1978. PMID: 347908 Review. No abstract available.